Showing results (1651-1660 of 2,000) with videos related to
Sort By:
Pageof 200
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 11, 2011
Longitudinal perceptions of prognosis and goals of therapy in patients with metastatic non-small-cell lung cancer: results of a randomized study of early palliative careJennifer S Temel, Joseph A Greer, Sonal Admane, et al.Cellular Signalling|May 21, 2005
In resting COS1 cells a dominant negative approach shows that specific, anchored PDE4 cAMP phosphodiesterase isoforms gate the activation, by basal cyclic AMP production, of AKAP-tethered protein kinase A type II located in the centrosomal regionAngela McCahill, Theresa McSorley, Elaine Huston, et al.Proceedings of the ... Annual Hawaii International Conference on System Sciences. Annual Hawaii International Conference on System Sciences|January 19, 2026
Detecting Ethanol Intoxication and Impairment Using Wearable BiosensorsEric E Kaczor, Manohar Golleru, Daniel C Carter, et al.Oncogene|May 18, 1995
Farnesyltransferase inhibitors are inhibitors of Ras but not R-Ras2/TC21, transformationJ M Carboni, N Yan, A D Cox, et al.Cancer Letters|August 28, 2004
MPO and SOD2 polymorphisms, gender, and the risk of non-small cell lung carcinomaGeoffrey Liu, Wei Zhou, Lisa I Wang, et al.Cell Motility and the Cytoskeleton|January 1, 1988
Regulation of the distribution of carotenoid droplets in goldfish xanthophores and possible implication to secretory processesT T Tchen, S J Lo, T J Lynch, et al.Nature Communications|October 12, 2017
Pan-Antarctic analysis aggregating spatial estimates of Adélie penguin abundance reveals robust dynamics despite stochastic noiseChristian Che-Castaldo, Stephanie Jenouvrier, Casey Youngflesh, et al.Biological Psychiatry|May 29, 2026
Focused Ultrasound Neuromodulation for Substance Use DisorderJames J Mahoney, Daisy G Y Thompson-Lake, Lucas Johnson, et al.Journal of Medicinal Chemistry|June 6, 1997
Non-peptide glycoprotein IIb/IIIa inhibitors. 17. Design and synthesis of orally active, long-acting non-peptide fibrinogen receptor antagonistsB C Askew, R A Bednar, B Bednar, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 4, 2005
Phase I trial of the matrix metalloproteinase inhibitor marimastat combined with carboplatin and paclitaxel in patients with advanced non-small cell lung cancerJohn R Goffin, Ian C Anderson, Jeffrey G Supko, et al.Pageof 200